Key publications appear in the World Journal of Gastroenterology and Current Pharmaceutical Design, detailing the healing of ulcers, fistulas, and other GI injuries in animal models
What insurance typically covers FDA-approved peptides for approved indications: Semaglutide (Ozempic) for type 2 diabetes: Often covered Semaglutide (Wegovy) for obesity: Sometimes covered with restrictions Tirzepatide (Mounjaro) for type 2 diabetes: Often covered Tirzepatide (Zepbound) for obesity: Limited coverage What coverage looks like: Prior authorization typically required Documentation of failed dietary interventions BMI thresholds for weight loss indications Co-pays still substantial ($100-500 monthly) What insurance doesn't cover The vast majority of peptide therapy falls outside insurance coverage: Compounded peptides (BPC-157, TB-500, most growth hormone peptides) Anti-aging applications even for FDA-approved drugs Performance enhancement uses Off-label applications These costs are entirely out-of-pocket for most patients
B12 is critical for red blood cell production, which ensures your tissues receive enough oxygen
How long does ProHealth suggest using BPC-157 before evaluating results
BPC-157 and TB-500 are two research peptides commonly studied together for their interaction with tissue-related signaling pathways in controlled laboratory environments
A trained provider will adjust your protocol based on how your symptoms respond, how the tissue heals, and in some cases, what shows up in your labs
